��������

Henry Weinstein is the current Director at Wellinks. Henry has held various positions in the pharmaceutical and healthcare industries throughout their career.

Weinstein began their career as a Salesman at FAV in June 2009. Henry then worked as a Training Sales Rep. at Gynopharm from June 2010 to August 2010. In May 2010, they joined CFR Pharmaceuticals as Vice President of Strategy and Innovation, a position they held until September 2014. Henry then moved to Abbott, where they served as Vice President of Strategy and Innovation from September 2014 to December 2016.

In January 2012, Weinstein became a Board Member of CONSORCIO TECNOLÓGICO EN BIOMEDICINA CLÍNICO-MOLECULAR S.A., a position they held until December 2016. Henry then joined Laniakea LLC as Director in December 2016. Henry has been with Wellinks since January 2017.

Henry Weinstein has a Bachelor of Arts in International Business from Regent's University London, a Certificate of Professional Development in Finance from The Wharton School, and a Management Acceleration Programme from INSEAD. Henry also has a Chinese Business degree from Zhejiang Gongshang University and a High School diploma from Craighouse School. Henry is certified in Leading Innovative Change: Executive Education Program with UC Berkeley Haas School of Executive Education and ExecOnline, Inc.